OUTLOOK THERAPEUTICS, INC. Increase Decrease In Operating Lease Liability
OUTLOOK THERAPEUTICS, INC. (OTLK) reported Increase Decrease In Operating Lease Liability of -$43.55 thousand for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-18.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-18
- OUTLOOK THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$14.82K.
- OUTLOOK THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$15.24K.
- OUTLOOK THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$13.50K.
- OUTLOOK THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$13.01K, a 330.91% decline year-over-year.
- OUTLOOK THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2025 was -$50.13K, a 1568.83% decline from fiscal 2024.
- OUTLOOK THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2024 was $3.41K.
- OUTLOOK THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2023 was -$27.00K.
- OUTLOOK THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2022 was -$42.85K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$14.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-18 | -$30.05K derived: sum of 2 quarters · filed 2026-08-18 | -$43.55K 10-Q · filed 2026-08-18 | -$56.56K derived: sum of 4 quarters · filed 2026-08-18 |
| 2026-03-31 | -$15.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-15 | -$28.74K 10-Q · filed 2026-05-15 | -$41.74K derived: sum of 3 quarters · filed 2026-05-15 | -$54.42K derived: sum of 4 quarters · filed 2026-08-18 |
| 2025-12-31 | -$13.50K 10-Q · filed 2026-02-17 | -$26.51K derived: sum of 2 quarters · filed 2026-02-17 | -$39.19K derived: sum of 3 quarters · filed 2026-08-18 | -$51.56K derived: sum of 4 quarters · filed 2026-08-18 |
| 2025-09-30 | -$13.01K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-19 | -$25.69K derived: sum of 2 quarters · filed 2026-08-18 | -$38.06K derived: sum of 3 quarters · filed 2026-08-18 | -$50.13K 10-K · filed 2025-12-19 |
| 2025-06-30 | -$12.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-18 | -$25.05K derived: sum of 2 quarters · filed 2026-08-18 | -$37.12K 10-Q · filed 2026-08-18 | -$31.49K derived: sum of 4 quarters · filed 2026-08-18 |
| 2025-03-31 | -$12.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-15 | -$24.44K 10-Q · filed 2026-05-15 | -$18.81K derived: sum of 3 quarters · filed 2026-05-15 | |
| 2024-12-31 | -$12.07K 10-Q · filed 2026-02-17 | -$6.44K derived: sum of 2 quarters · filed 2026-02-17 | ||
| 2024-09-30 | $5.63K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-19 | $3.41K 10-K · filed 2025-12-19 | ||
| 2024-06-30 | -$2.22K 10-Q · filed 2025-08-14 | |||
| 2023-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-27 | -$3.93K derived: sum of 2 quarters · filed 2024-12-27 | -$15.57K derived: sum of 3 quarters · filed 2024-12-27 | -$27.00K 10-K · filed 2024-12-27 |
| 2023-06-30 | -$3.93K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-14 | -$15.57K derived: sum of 2 quarters · filed 2024-08-14 | -$27.00K 10-Q · filed 2024-08-14 | -$38.20K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$11.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-15 | -$23.07K 10-Q · filed 2024-05-15 | -$34.27K derived: sum of 3 quarters · filed 2024-05-15 | -$45.17K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$11.42K 10-Q · filed 2024-02-14 | -$22.63K derived: sum of 2 quarters · filed 2024-02-14 | -$33.53K derived: sum of 3 quarters · filed 2024-02-14 | -$44.01K derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-09-30 | -$11.21K derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-22 | -$22.11K derived: sum of 2 quarters · filed 2023-12-22 | -$32.59K derived: sum of 3 quarters · filed 2023-12-22 | -$42.85K 10-K · filed 2023-12-22 |
| 2022-06-30 | -$10.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-14 | -$21.38K derived: sum of 2 quarters · filed 2023-08-14 | -$31.65K 10-Q · filed 2023-08-14 | -$41.72K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$10.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-15 | -$20.75K 10-Q · filed 2023-05-15 | -$30.82K derived: sum of 3 quarters · filed 2023-05-15 | -$79.37K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$10.27K 10-Q · filed 2023-02-14 | -$20.34K derived: sum of 2 quarters · filed 2023-02-14 | -$68.89K derived: sum of 3 quarters · filed 2023-02-14 | -$115.28K derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-09-30 | -$10.07K derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-29 | -$58.63K derived: sum of 2 quarters · filed 2022-12-29 | -$105.01K derived: sum of 3 quarters · filed 2022-12-29 | -$150.35K 10-K · filed 2022-12-29 |
| 2021-06-30 | -$48.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-10 | -$94.94K derived: sum of 2 quarters · filed 2022-08-10 | -$140.27K 10-Q · filed 2022-08-10 | |
| 2021-03-31 | -$46.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-13 | -$91.72K 10-Q · filed 2022-05-13 | ||
| 2020-12-31 | -$45.34K 10-Q · filed 2022-02-14 | |||
| 2020-09-30 | -$164.69K 10-K · filed 2021-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |